NCT07522957

Brief Summary

This study aims to compare two commonly used airway devices (I-gel and Air-Q) in children aged 1-10 years undergoing general anesthesia for surgery. These devices help doctors keep the airway open and support breathing during the operation. The study will evaluate how well each device works, how easy they are to place, and whether they cause air to enter the stomach. Ultrasound will be used to safely check the position of the device and detect any air in the stomach. The results of this study may help improve the safety and effectiveness of airway management in children during anesthesia.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 13, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

March 27, 2026

Last Update Submit

April 21, 2026

Conditions

Keywords

Airway managementLaryngeal mask airwayPediatric patientsUltrasonographyGastric insufflationSupraglottic airway devices

Outcome Measures

Primary Outcomes (1)

  • Oropharyngeal Leak Pressure (OLP)

    Measured in cmH₂O after device placement and at the end of surgery using standard anesthesia machine settings (fresh gas flow 3 L/min, APL valve set to 30 cmH₂O).

    Immediately after device placement and at the end of the surgical procedure during anesthesia

Secondary Outcomes (5)

  • Gastric Insufflation

    Immediately after device placement and at the end of surgery

  • Device Position

    Immediately after device placement, after patient positioning, and at the end of surgery

  • Insertion Time

    At the time of device placement (periprocedural)

  • Ease of Insertion

    At the time of device placement (periprocedural)

  • Perioperative Complications

    From device placement until discharge from the Post-Anesthesia Care Unit (PACU), up to 2 hours

Study Arms (2)

I-Gel Group

Participants in this group will receive the I-gel laryngeal mask airway during general anesthesia. After placement, oropharyngeal leak pressure will be measured, and ultrasonography will be used to assess device position and detect gastric insufflation. Additional parameters such as insertion time, ease of insertion, and perioperative complications will be recorded.

Device: I-gel supraglottic airway device

Air-Q SP Group

Participants in this group will receive the Air-Q SP laryngeal mask airway during general anesthesia. Similar measurements will be performed, including oropharyngeal leak pressure, ultrasonographic evaluation of device position and gastric insufflation, insertion time, ease of insertion, and perioperative complications.

Device: Air-Q SP supraglottic airway device

Interventions

I-gel Laryngeal Mask Airway: The I-gel is a second-generation supraglottic airway device with a non-inflatable cuff designed to provide an anatomical seal of the airway. In this study, the device will be selected according to patient weight and inserted following standard clinical practice during general anesthesia. Its performance will be evaluated using oropharyngeal leak pressure measurements and ultrasonographic assessment of gastric insufflation and device position.

Also known as: I-gel laryngeal mask airway
I-Gel Group

Air-Q SP Laryngeal Mask Airway: The Air-Q SP is a supraglottic airway device with a self-pressurizing, non-inflatable cuff designed to provide effective airway sealing. It will be selected based on patient weight and inserted using standard techniques. Its performance will be assessed using the same parameters as the I-gel, including oropharyngeal leak pressure, ultrasonographic evaluation of gastric insufflation, and device positioning.

Also known as: Air-Q SP laryngeal mask airway
Air-Q SP Group

Eligibility Criteria

Age1 Year - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of children aged 1-10 years who are scheduled for elective surgical procedures under general anesthesia at a tertiary care hospital. Participants will be selected from patients with American Society of Anesthesiologists (ASA) physical status I-II, representing generally healthy pediatric individuals. All eligible patients will be recruited from the operating room setting after obtaining written informed consent from their parents or legal guardians.

You may qualify if:

  • Children aged 1-10 years
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Scheduled for elective (non-emergency) surgery under general anesthesia
  • Planned use of a supraglottic airway device for airway management
  • Written informed consent obtained from a parent or legal guardian

You may not qualify if:

  • History of conditions associated with increased risk of aspiration (e.g., gastroesophageal reflux)
  • Known or predicted difficult airway (e.g., Mallampati score ≥ 3)
  • Congenital or acquired abnormalities of the face, neck, or upper airway
  • Active upper respiratory tract infection
  • Presence of significant pulmonary disease (e.g., asthma, bronchopulmonary dysplasia, cystic fibrosis)
  • Body mass index above the 95th percentile for age (morbid obesity)
  • Emergency surgery
  • Previous complications related to supraglottic airway device use
  • Failure of device placement or need to switch to an alternative airway management technique
  • Refusal of participation by parent or legal guardian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Etlik, 06170, Turkey (Türkiye)

RECRUITING

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

March 27, 2026

First Posted

April 13, 2026

Study Start

April 1, 2026

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations